Top Markets
Coin of the day
Bioptik Technology Incorporation Bioptik Technology Incorporation

Bioptik Technology Incorporation

4161
株式のランク #26077
Bioptik Technology Incorporation operates as a global entity, focusing on the... Bioptik Technology Incorporation operates as a global entity, focusing on the creation and distribution of medical instruments and diagnostic chemicals. The company's product line encompasses the EasyMate series of blood glucose monitoring systems, as well as comprehensive diagnostic devices designed to measure blood glucose, cholesterol, and uric acid levels, complete with their essential test strips. Beyond its healthcare offerings, Bioptik also provides a range of skincare solutions, including those formulated with hyaluronic acid, alongside various dietary supplements. Uniquely, the company diversifies its business by supplying biodiesel products. Founded in 1999, Bioptik Technology Incorporation is headquartered in Zhunan, Taiwan.
株価
$0.72978769
最終同期: 2026-08-20
時価総額
$43.65M
変化(1日)
1.10%
変化(1年)
-18.53%
TW
取引 Bioptik Technology Incorporation (4161)

カテゴリー

Bioptik Technology Incorporation(4161)のEPS
2026 時点のEPS TTM: 0
Bioptik Technology Incorporationの最新の財務報告と株価によると、同社の現在のEPS(TTM)は0です。2026年末には、EPSは0で、2026年のEPS0と同等でした。
Bioptik Technology IncorporationのEPS履歴(2026から2026まで)
各年末時点のEPS
EPS 変化
提供された日付のデータは十分ではありません。
同様の企業または競合他社のEPS